Skip to main content
Top
Published in: Malaria Journal 1/2020

Open Access 01-12-2020 | Plasmodium Falciparum | Research

Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature

Authors: Nadia Castaldo, Carlo Tascini, Paola Della Siega, Maddalena Peghin, Davide Pecori

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

Background

Malaria still represents a major health threat, in terms of both morbidity and mortality. Complications of malaria present a diversified clinical spectrum, with neurological involvement leading to the most serious related-conditions. The authors recently encountered a case of a 60-year old Italian man presenting with confusion, language disturbances and Parkinson-like syndrome 3 weeks after complete remission from severe Plasmodium falciparum cerebral malaria. Chemical and microbiological analysis revealed aseptic meningitis, diffuse encephalitis and abnormal immune-activation. Re-infection and recrudescence of infection were excluded. Further analysis excluded paraneoplastic and autoimmune causes of encephalitis. A diagnosis of Post-Malaria Neurological Syndrome (PMNS) was finally formulated and successfully treated with high dose of steroids.

Methods

A systematic research of current literature related to PMNS was performed.

Results

151 cases of PMNS were included, the majority of which occurred after severe P. falciparum infections. Four main clinical pattern were identified: 37% of the cases presented as “classical” PMNS, 36% presented as delayed cerebellar ataxia (DCA), 18% resembled acute inflammatory demyelinating polyneuropathy (AIDP), and 8% presented as acute disseminated encephalomyelitis (ADEM)-like form. Differentiation between different forms was not always simple, as clinical and radiological findings frequently overlap. Overall, in almost all of the tested cases, cerebrospinal fluid was found pathological; EEG revealed nonspecific encephalopathy in 30% of classical PMNS and 67% ADEM; imaging tests were found abnormal in 92% of ADEM-like forms. Pathogenesis remains unclear. An autoimmune mechanism is the most corroborated pathogenic hypothesis. Overall, the majority of PMNS cases revert without specific treatment. In most severe forms, high dose steroids, intravenous immunoglobulins, and plasmapheresis have been shown to improve symptoms.

Conclusions

PMNS is a disabling complication of malaria. The overall incidence is not known, due to frequent misdiagnosis and under-reporting. Pathogenesis is not also fully understood, but rapid response to immune-modulating treatment along with similarities to auto-immune neurological disease, strongly support a dysregulated immunological genesis of this condition. The lack of randomized controlled studies regarding therapeutic approaches is a major unmet need in this setting. A systematic collection of all the PMNS cases would be desirable, in order to increase awareness of this rare condition and to prospectively investigate the most appropriate management.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO. World malaria report 2019. Geneva: World Health Organization; 2019. WHO. World malaria report 2019. Geneva: World Health Organization; 2019.
2.
go back to reference Kihara M, Carter JA, Newton CR. The effect of Plasmodium falciparum on cognition: a systematic review. Trop Med Int Health. 2006;11:386–97.CrossRef Kihara M, Carter JA, Newton CR. The effect of Plasmodium falciparum on cognition: a systematic review. Trop Med Int Health. 2006;11:386–97.CrossRef
3.
go back to reference Mishra SK, Newton CR. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol. 2009;5:189–98.CrossRef Mishra SK, Newton CR. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol. 2009;5:189–98.CrossRef
4.
go back to reference Nguyen TH, Day NP, Ly VC, Waller D, Mai NT, Bethell DB, et al. Post-malaria neurological syndrome. Lancet. 1996;348:917–21.CrossRef Nguyen TH, Day NP, Ly VC, Waller D, Mai NT, Bethell DB, et al. Post-malaria neurological syndrome. Lancet. 1996;348:917–21.CrossRef
5.
go back to reference Poulet A, Bou Ali H, Savini H, Kaphan E, Parola P. Post-malaria neurological syndrome: Imported case series and literature review to unscramble the auto-immune hypothesis. Travel Med Infect Dis. 2019;29:16–20.CrossRef Poulet A, Bou Ali H, Savini H, Kaphan E, Parola P. Post-malaria neurological syndrome: Imported case series and literature review to unscramble the auto-immune hypothesis. Travel Med Infect Dis. 2019;29:16–20.CrossRef
6.
go back to reference Carreira J, Casella MI, Ascencao BB, Luis NP, Goncalves AC, Brito AP, et al. Acute disseminated encephalomyelitis, a rare post-malaria neurological complication: case report and review of the literature. Travel Med Infect Dis. 2019;28:81–5.CrossRef Carreira J, Casella MI, Ascencao BB, Luis NP, Goncalves AC, Brito AP, et al. Acute disseminated encephalomyelitis, a rare post-malaria neurological complication: case report and review of the literature. Travel Med Infect Dis. 2019;28:81–5.CrossRef
7.
go back to reference Markley JD, Edmond MB. Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med. 2009;16:424–30.CrossRef Markley JD, Edmond MB. Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med. 2009;16:424–30.CrossRef
8.
go back to reference Tamzali Y, Demeret S, Haddad E, Guillot H, Caumes E, Jaureguiberry S. Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework. Malar J. 2018;17:387.CrossRef Tamzali Y, Demeret S, Haddad E, Guillot H, Caumes E, Jaureguiberry S. Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework. Malar J. 2018;17:387.CrossRef
9.
go back to reference Panda PK, Sharawat IK, Panda PK. An adolescent girl with isolated neuropsychiatric features and apparent post-malaria neurological syndrome. Am J Trop Med Hyg. 2020;102:1030–2.CrossRef Panda PK, Sharawat IK, Panda PK. An adolescent girl with isolated neuropsychiatric features and apparent post-malaria neurological syndrome. Am J Trop Med Hyg. 2020;102:1030–2.CrossRef
10.
go back to reference Mizuno Y, Kato Y, Kanagawa S, Kudo K, Hashimoto M, Kunimoto M, et al. A case of postmalaria neurological syndrome in Japan. J Infect Chemother. 2006;12:399–401.CrossRef Mizuno Y, Kato Y, Kanagawa S, Kudo K, Hashimoto M, Kunimoto M, et al. A case of postmalaria neurological syndrome in Japan. J Infect Chemother. 2006;12:399–401.CrossRef
11.
go back to reference Teo JT, Swayne OB, Silber E. Cerebellar ataxia after malaria. Neurology. 2009;73:73–4.CrossRef Teo JT, Swayne OB, Silber E. Cerebellar ataxia after malaria. Neurology. 2009;73:73–4.CrossRef
12.
go back to reference Singh AK, Chakraborty S, Subhranag S. Post-malaria neurological syndrome—a case of Bell’s palsy after Plasmodium vivax malaria. J Nepal Paed Soc. 2013;33:66–7.CrossRef Singh AK, Chakraborty S, Subhranag S. Post-malaria neurological syndrome—a case of Bell’s palsy after Plasmodium vivax malaria. J Nepal Paed Soc. 2013;33:66–7.CrossRef
13.
go back to reference Yadava SK, Laleker A, Fazili T. Post-malaria neurological syndrome: a rare neurological complication of malaria. Infection. 2019;47:183–93.CrossRef Yadava SK, Laleker A, Fazili T. Post-malaria neurological syndrome: a rare neurological complication of malaria. Infection. 2019;47:183–93.CrossRef
14.
go back to reference Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, et al. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology. 2016;87(Suppl 2):S38-45.CrossRef Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, et al. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology. 2016;87(Suppl 2):S38-45.CrossRef
15.
go back to reference Kasundra GM, Bhargava AN, Bhushan B, Shubhakaran K, Sood I. Post-Plasmodium vivax malaria cerebellar ataxia and optic neuritis: a new form of delayed cerebellar ataxia or cerebellar variant of acute disseminated encephalomyelitis? J Pediatr Neurosci. 2015;10:58–60.PubMedPubMedCentral Kasundra GM, Bhargava AN, Bhushan B, Shubhakaran K, Sood I. Post-Plasmodium vivax malaria cerebellar ataxia and optic neuritis: a new form of delayed cerebellar ataxia or cerebellar variant of acute disseminated encephalomyelitis? J Pediatr Neurosci. 2015;10:58–60.PubMedPubMedCentral
16.
go back to reference Sahuguet J, Poulet A, Bou Ali H, Parola P, Kaphan E. Postmalaria Neurologic Syndrome-autoimmune encephalitis with anti-voltage-gated potassium-channel antibodies. Ann Intern Med. 2017;167:70–1.CrossRef Sahuguet J, Poulet A, Bou Ali H, Parola P, Kaphan E. Postmalaria Neurologic Syndrome-autoimmune encephalitis with anti-voltage-gated potassium-channel antibodies. Ann Intern Med. 2017;167:70–1.CrossRef
17.
go back to reference Palmieri F, Petrosillo N, Paglia MG, Conte A, Goletti D, Pucillo LP, et al. Genetic confirmation of quinine-resistant Plasmodium falciparum malaria followed by postmalaria neurological syndrome in a traveler from Mozambique. J Clin Microbiol. 2004;42:5424–6.CrossRef Palmieri F, Petrosillo N, Paglia MG, Conte A, Goletti D, Pucillo LP, et al. Genetic confirmation of quinine-resistant Plasmodium falciparum malaria followed by postmalaria neurological syndrome in a traveler from Mozambique. J Clin Microbiol. 2004;42:5424–6.CrossRef
18.
go back to reference Donati D, Zhang LP, Chene A, Chen Q, Flick K, Nystrom M, et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun. 2004;72:5412–8.CrossRef Donati D, Zhang LP, Chene A, Chen Q, Flick K, Nystrom M, et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun. 2004;72:5412–8.CrossRef
19.
go back to reference Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2016;80:151–201.CrossRef Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2016;80:151–201.CrossRef
20.
go back to reference Hsieh CF, Shih PY, Lin RT. Postmalaria neurologic syndrome: a case report. Kaohsiung J Med Sci. 2006;22:630–5.CrossRef Hsieh CF, Shih PY, Lin RT. Postmalaria neurologic syndrome: a case report. Kaohsiung J Med Sci. 2006;22:630–5.CrossRef
21.
go back to reference Kampfl A, Pfausler B, Haring HP, Denchev D, Donnemiller E, Schmutzhard E. Impaired microcirculation and tissue oxygenation in human cerebral malaria: a single photon emission computed tomography and near-infrared spectroscopy study. Am J Trop Med Hyg. 1997;56:585–7.CrossRef Kampfl A, Pfausler B, Haring HP, Denchev D, Donnemiller E, Schmutzhard E. Impaired microcirculation and tissue oxygenation in human cerebral malaria: a single photon emission computed tomography and near-infrared spectroscopy study. Am J Trop Med Hyg. 1997;56:585–7.CrossRef
22.
go back to reference de Silva HJ, Hoang P, Dalton H, de Silva NR, Jewell DP, Peiris JB. Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 1992;86:129–31.CrossRef de Silva HJ, Hoang P, Dalton H, de Silva NR, Jewell DP, Peiris JB. Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 1992;86:129–31.CrossRef
24.
go back to reference Senanayake N. Delayed cerebellar ataxia: a new complication of falciparum malaria? BMJ. 1987;294:1253–4.CrossRef Senanayake N. Delayed cerebellar ataxia: a new complication of falciparum malaria? BMJ. 1987;294:1253–4.CrossRef
25.
go back to reference Forestier E, Labe A, Raffenot D, Lecomte C, Rogeaux O. Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment. Med Mal Infect. 2011;41:41–3.CrossRef Forestier E, Labe A, Raffenot D, Lecomte C, Rogeaux O. Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment. Med Mal Infect. 2011;41:41–3.CrossRef
26.
go back to reference Sonneville R, Klein I, de Broucker T, Wolff M. Post-infectious encephalitis in adults: diagnosis and management. J Infect. 2009;58:321–8.CrossRef Sonneville R, Klein I, de Broucker T, Wolff M. Post-infectious encephalitis in adults: diagnosis and management. J Infect. 2009;58:321–8.CrossRef
27.
go back to reference Schnorf H, Diserens K, Schnyder H, Chofflon M, Loutan L, Chaves V, et al. Corticosteroid-responsive postmalaria encephalopathy characterized by motor aphasia, myoclonus, and postural tremor. Arch Neurol. 1998;55:417–20.CrossRef Schnorf H, Diserens K, Schnyder H, Chofflon M, Loutan L, Chaves V, et al. Corticosteroid-responsive postmalaria encephalopathy characterized by motor aphasia, myoclonus, and postural tremor. Arch Neurol. 1998;55:417–20.CrossRef
28.
go back to reference John CC, Kutamba E, Mugarura K, Opoka RO. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther. 2010;8:997–1008.CrossRef John CC, Kutamba E, Mugarura K, Opoka RO. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther. 2010;8:997–1008.CrossRef
29.
go back to reference Taylor TE, Molyneux ME, Wirima JJ, Borgstein A, Goldring JD, Hommel M. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin Exp Immunol. 1992;90:357–62.CrossRef Taylor TE, Molyneux ME, Wirima JJ, Borgstein A, Goldring JD, Hommel M. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin Exp Immunol. 1992;90:357–62.CrossRef
30.
go back to reference Stangel M, Compston A. Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors. J Neuroimmunol. 2001;112:63–71.CrossRef Stangel M, Compston A. Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors. J Neuroimmunol. 2001;112:63–71.CrossRef
31.
go back to reference Mitrevski M, Marrapodi R, Camponeschi A, Cavaliere FM, Lazzeri C, Todi L, et al. Intravenous immunoglobulin and immunomodulation of B-cell - in vitro and in vivo effects. Front Immunol. 2015;6:4.CrossRef Mitrevski M, Marrapodi R, Camponeschi A, Cavaliere FM, Lazzeri C, Todi L, et al. Intravenous immunoglobulin and immunomodulation of B-cell - in vitro and in vivo effects. Front Immunol. 2015;6:4.CrossRef
32.
go back to reference Kazatchkine MD, Bellon B, Kaveri SV. Mechanisms of action of intravenous immunoglobulin (IVIG). Mult Scler. 2000;6(Suppl 2):S24–6.CrossRef Kazatchkine MD, Bellon B, Kaveri SV. Mechanisms of action of intravenous immunoglobulin (IVIG). Mult Scler. 2000;6(Suppl 2):S24–6.CrossRef
33.
go back to reference Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol. 2002;249:100–4.CrossRef Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol. 2002;249:100–4.CrossRef
34.
go back to reference Ravaglia S, Piccolo G, Ceroni M, Franciotta D, Pichiecchio A, Bastianello S, et al. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J Neurol. 2007;254:1518–23.CrossRef Ravaglia S, Piccolo G, Ceroni M, Franciotta D, Pichiecchio A, Bastianello S, et al. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J Neurol. 2007;254:1518–23.CrossRef
35.
go back to reference Berkowitz AL, Thakur KT. Acute inflammatory demyelinating polyradiculoneuropathy following malaria. J Clin Neurosci. 2014;21:704–6.CrossRef Berkowitz AL, Thakur KT. Acute inflammatory demyelinating polyradiculoneuropathy following malaria. J Clin Neurosci. 2014;21:704–6.CrossRef
36.
go back to reference Chakravarty A, Ghosh B, Bhattacharyya R, Sengupta S, Mukherjee S. Acute inflammatory demyelinating polyneuropathy following plasmodium vivax malaria. Neurol India. 2004;52:130–1.PubMed Chakravarty A, Ghosh B, Bhattacharyya R, Sengupta S, Mukherjee S. Acute inflammatory demyelinating polyneuropathy following plasmodium vivax malaria. Neurol India. 2004;52:130–1.PubMed
Metadata
Title
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature
Authors
Nadia Castaldo
Carlo Tascini
Paola Della Siega
Maddalena Peghin
Davide Pecori
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03476-2

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.